Institute of Kidney Diseases & Research Centre (IKDRC)Institute of Transplantation Sciences (ITS)

Civil Hospital Campus, Asarwa, Ahmedabad – 380016Gujarat, INDIA

Website : www.ikdrc-its.org

Prof. Hargovind Laxmishanker Trivedi

CURRICULUM VITAE

Name : Hargovind Laxmishanker Trivedi

Registration number : G-120

Birth Date : August 31st, 1932

Home Address : B/1, Riddhi Siddhi Appt., B/h Circuit House, Nr. State BankColony, Shahibaug, Ahmedabad – 380 004

Office Address : Prof. & Director, Institute of Kidney Diseases & Research Centre(IKDRC) Institute of Transplantation Sciences (ITS), CivilHospital Campus, Asarwa, Ahmedabad – 380016, Gujarat, INDIA

Telephone Nos : Res: +91 79 2268 4545

Off: +91 79 2268 56 00 – 09 (Expect 03)

Direct line : +91 79 2268 57 00

Fax no. : +91 79 2268 54 54

Official E-mail : ikdrcad1@sancharnet.in

Alternate E-mail : hltrivedi@ikdrc-its.org

Marital Status : Married

2

E D U C A T I O N

Jun 1951 - May 1953 Faculty of Science (Pre-Medical), Dharmendra Sinhji College, Rajkot, India.

Jun 1953 - Jun 1963 M. B.B.S. (Including one year internship), B.J.Medical College, To June 1963Ahmedabad, India.

1963 Permanent certificate E.C.F.M.G.

Jul 1963 – Jun 1965

Residency in Internal Medicine, Lakewood Hospital, Lakewood, Ohio, USA,(AMA approved), including six months in cardiopulmonary services, V.A. Hospital, Cleveland, Ohio, USA.

Jul 1965 – Jun 1966Chief Resident, Internal Medicine, Lakewood Hospital, Lakewood, Ohio, USA (AMA approved).

July 1966 – Aug 1967Resident in Nephrology, Cleveland Clinic and St. John Hospital, Cleveland, Ohio, U.S.A.

Fellow of American College of Chest Physicians (F.C.C.P.).

Sep 1967 – Aug 1968Fourth year Resident Internal Medicine, Nephrology and Cardio-pulmonary services,Case Western Reserve University Hospital, Cleveland, Ohio, U.S.A.

Sep 1968 – Jun 1969Resident in Nephrology, St. Joseph's Teaching Hospital, McMaster University, Hamilton,Ontario, Canada.

1969Fellow of the Royal College of Physicians and Surgeons of Canada F.R.C.P. (C).

American Board Diplomat, Internal Medicine.

3

FACULTY APPOINTMENTS HELD

IN INDIA

1960 -1962 Junior Lecturer, Department of Anatomy, B. J. Medical College, Ahmedabad.

IN CANADA 1st July, 1970 - 31 June, 1971

Lecturer in Medicine (Nephrology), Nephrologist in-charge of Hemodialysis unit, McMaster University, Hamilton, Ontario.

1 July, 1971 - March 1974Asst. Professor in Medicine (Nephrology), Associate Director of Dialysis

Service, McMaster University, Hamilton, Ontario.

1 April, 1974 – 16 Jan. 1977Medical Director, Regional Kidney Transplantation Programme, McMaster University,Hamilton, Ontario.

16 Jan, 1977 – OnwardsWorked Exclusively in the Dept. of Nephrology, McMaster University, Hamilton, Ontario.

IN INDIA

17 Jan, 1977 - 7 Oct. 1981Professor of Medicine (Nephrology), Head, Nephrology Service, B.J. Medical College, Civil Hospital, Ahmedabad.

8 Oct, 1981 – Jun 1997Director - Professor, Institute of Kidney Diseases & Research Centre, Ahmedabad.

June 1997 onwards

Director-Professor, Institute of Kidney Diseases & Research Centre, Institute ofTransplantation Sciences, Ahmedabad.

P R I Z E S

June 1964 Winner of Lakewood Hospital Annual Clinical Research Contest paper, "Lupus

Nephritis".

June 1964Co-Winner (with R.M. Carungin M.D.) of Lakewood Hospital Annual Research Contestfor 'Radiation Pericarditis".

4

PROFILE OF ACADEMIC ACTIVITIES

1973: Visiting Professor for 3 Months to B.J. Medical College, Ahmedabad, from McMaster University, Canada

1973 – 1975: Regional Representative, Ontario Medical Association 1976: Chairman, Scientific Papers Session, 6th Annual Conference of the Indian Society of Nephrology, New Delhi, India- January.

1976 – 1977: Vice-President Elect, Indian Society of Nephrology

1978: Vice-President Elect, Indian Society of Nephrology

1980: President Elect, Indian Society of Nephrology

1981: Chairman for Symposium on Dialysis and Transplantation meeting in Nagpur, India Visiting Professor, McMaster University, Canada Visiting Professor, Alberta Heritage Foundation, University of Alberta, Canada Visiting Scientist Stanford University, California, U.S.A. Heritage Foundation - Visiting Professor, University of Alberta, Canada Examiner DM Nephrology, Madras University

1982: Founder and Chairman Shri Bhagwatprasad Ranchhoddas Nephrology Oration. Founder and Chairman- Parry's Oration in Nephrology

1983 : Examiner- D.M. Nephrology, P.G.I. Chandigarh Member of National Board of Examinations, India Visiting Professor B.H.U., Varanasi, India Member of Board of Studies B.H.U. Varanasi, India

1984: Fellow of Indian Society of Nephrology

1987: Judge - Annual Session, Western Chapter, Indian Society of Nephrology 1988:

Founder Trustee and Member Secretary, Governing body of G.R.Doshi and K.M. MehtaInstitute of Kidney Diseases and Research Centre (IKDRC), Ahmedabad

Member Advisory Committee, World Conference- `A Global view, Ethics, Justice andCommerce in transplantation’. Ottawa, Canada

Chairman of the Session on different religious views concerning the dead body. Global Conference on Ethics, Justice and Commerce on Transplantation. Ottawa, Canada Organizing Secretary, First Annual Meeting, Indian Society of Organ Transplantation.

1996: Chairman - Organising Committee- First International Congress on Transplantation and

Kidney Diseases. Ahmedabad. India.

5

Member Secretary, Distinguished Teachers’ Award Distribution and Life TimeAchievement Awards Committee, IKDRC – ITS, Ahmedabad.

1997: Founder Director-Professor -Institute of Transplantation Sciences, Ahmedabad, India.

1998: Chairman - Organising Committee, Second International Congress on Transplantation,

Kidney Diseases and Critical Care, Ahmedabad Member Secretary, Golden Jubilee Celebration – Distinguished Teachers’ Award Distribution

Committee, IKDRC – ITS, Ahmedabad, India.

2000: Chairman- Organizing Committee, 2nd International Congress on Transplantation, KidneyDiseases and Critical Care, Ahmedabad.

: Chairman - Organizing Committee, “Transplantation Update 2002”, Ahmedabad.

2005 : Chairman - Organizing Committee, “CME and IV International Congress on Kidney

Diseases”, Ahmedabad. Chairman - Organizing Committee, “CME on Renal and Transplantation Pathology,

Stem Cell Transplantation and Preventive Nephrology, and XVII Annual Conference ofIndian Society of Organ Transplantation”, Ahmedabad.

2007: Chairman – Organizing Committee, “Transplantation Update 2007”, Liver, Kidney and Stem Cells Transplantation, Ahmedabad.

2008: Chairman of Symposium on Nephrotic syndrome in children organized by Nestle Nutrition Institute of India, Ahmedabad, 7th September, 2008.

2009: Chairman- Organizing Committee, “Transplantation Update 2009” (Kidney, Stem Cellsand Immune Tolerance), Ahmedabad.

2010: Chairman – Organizing Committee, “Transplantation Update 2010” (Transplantation

without Conventional Immunosuppression- Kidney, Liver and Stem Cells),Ahmedabad. Chairman – Organizing Committee, “International Workshop on Advance Laparoscopic

Urological Surgery”, Ahmedabad.

2011: Chairman – Organizing Committee, “Transplantation Update 2011”, Ahmedabad.

2012: Chairman – Organizing Committee, “Transplantation Update 2012”, Ahmedabad.

2013: Chairman – Organizing Committee, “Transplantation Update 2013”, Ahmedabad.

6

PROFILE OF CREATIVITY

1974: Founded “Hamilton Organ Procurement Program” (HOPE), McMaster University, Hamilton, Ontario, Canada.

1975: Founded of "Bannerman Hemingway Nephrology Library, McMaster University, Hamilton, Ontario, Canada.

1983: Founded “G.R.Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre”

(IKDRC), Ahmedabad, Gujarat, India. Founder Editor, Bulletin-IKDRC, Ahmedabad, Gujarat, India. Founded Indian Society of Organ Transplantation.

1985: Founder Editor, Indian Journal of Nephrology.

1997: Founded “Institute of Transplantation Sciences” (ITS), Ahmedabad, Gujarat, India.

1998: Established “Maharshi Sushruta Gnyaanpeeth Sanmaan For Transplantation Biology”, Institute of Transplantation Sciences (ITS), Ahmedabad, Gujarat, India.

2000: Founder Editor, Journal –“Transplantation India”, Headquarter - Institute of Transplantation Sciences (ITS), Ahmedabad, Gujarat, India.

2004: Institute of Transplantation Sciences (ITS) named as Dr. H.L. Trivedi Institute ofTransplantation Sciences (ITS)

2005: Founder member of the International Society of Innate Immunity Established “Sandipani Rishi Gnyaanpeeth Sanmaan” For Life Time Committed to

Teaching in Medical Science in the area of Nephrology, Urology, Transplantation Sciences and Related Branches, Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Ahmedabad, Gujarat, India.

Established “Bhagwaan Dhanwantari Gnyaanpeeth Sanmaan” for Extraordinary Research In Nephrology, Urology and Transplantation Sciences, Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Ahmedabad, Gujarat, India.

“Bhagwaan Mahavir Karuna Sewa Sanmaan”, April 2007. Dr. H. L. Trivedi Gold Medal Established by Dr. H. L. Trivedi Foundation for Medical

Education, Research and Services, December 2007. Dadhichi Rushi Sewa Sanmaan Established to Boost Deceased Donor Organ

Transplantation, May 2007.

2009: Founder Editor, ADPKD News Letter, January, 2009

7

FELICITATIONS, CITATIONS AND HONORS

1990: Felicitation by People of Dhrangadhra, Gujarat, India. Vijayshree Award from International Friendship Society of India. Felicitation by People of Chandod, Mandava, from Gujarat, India.

1992: Vikas Rattan Award from International Friendship Society of India.

1993: Felicitation by People of Lakhtar, India. Felicitation by Municipal Corporation of Gondal, Gujarat, India.

1994: Sadvichar Samarpan Award, Ahmedabad, India. Gandhi Smruti Campaign for Education In Kidney Diseases, Ahmedabad, India. Shri Ambedkar Centenary Sewa Peeth Sanman, Gujarat, India.

1995: Sewa Pravruti Bahuman” FoolChhab Parivar, on FoolChhab Platinam Jayanti Mahotsav.

1996 : Shree Maganbhai Desai Government Award.

1998: Felicitation by Halvad Brahm Samaj, Ahmedabad. “Sanmaan Patra” by Lions Club International.

1999: Felicitation by Academy of Ayurveda Development and Research, Ahmedabad. India. Felicitation by "Shri Mota" 77th Diksha Din Ceremony, Nadiad. Shree Natubhai Thakkar Foundation Award for “Sahitya, Shikshan and Samskaar”,

Ahmedabad, India. Diwaliben Mohanlal Mehta Award for Excellence in Management of Kidney Institute,

Mumbai, India. Hon.Nephrologist to H.E. the Governor of Gujarat, India. Millennium Oration Award from Shri M.P.Shah Medical College, Jamnagar. Halwad Ratna Award, Gujarat, India.

2000: Gaurav Puraskar by Govt. of Gujarat, India for Contribution towards Medical Education. “Felicitation by Human Society of India” for Excellent Services in Medical Field, Nadiad,

Gujarat, India. “South Ahmedabad Junior Chamber”, Ahmedabad for excellence in Medical Care

Services.

2002: Felicitation by People of Charadava.

2003: “Rashtriya Education Seva Pratisthan, Halvad”, for Excellence in Medical Care Services. Swami Vivekanand Sadbhav Seva Award. Indian Medical Association ‘Appreciation Award’

2004: S.G.P.G.I., Lucknow, for his Pioneering Work in the field of Transplantation Tolerance. Scroll of Honor for Pioneering Hemodialysis by Indian Society of Hemodialysis.

2005: Citation from Banaras Hindu University, Department of Nephrology, Varanasi.

2006: Felicitation by Halvad Brahmin Samaj. Felicitation by “Divyabhaasker” newspaper as one of the “100 Most Powerful Persons of

Gujarat” for his Development of Nephrology and Transplantation Services in India.

8

Pratidhwani Media Award – 2005 for Excellence Medical Activities, Rajkot. Felicitation by Pramukhswami Maharaj of Aksharpurushottam Swaminarayan Mandir,

Ahmedabad. Institute of Transplantation Sciences established by him named as “Dr. H.L. Trivedi

Institute of Transplantation Sciences”. Felicitation by Gujarat Brahmin Samaaj, Ahmedabad.

2007 : Pride of Gujarat - 2007 Award Felicitation by Feelings Magazine, Baroda. Felicitation by Rotary Clubs of Ahmedabad. “Prof. P. Venugopal Oration”, Mysore on the Amazing World Of Stem Cells. “Lifetime Achievement Award” for the Significant Contributions in Hypertension and

Kidney Disorders by the Madras Kidney Trust & Hypertension Research Foundation). Balaji Gold Medal by Shri Venkateshwara University, Tirupati.

2008 : Honored as pioneer in health services under “Spirit of India” by India Today. Felicitation by Rotary Club of Ahmedabad Airport. Felicitation by “Divyabhaasker” newspaper as one of the “100 Most Powerful Persons of

Gujarat” for his Development of Nephrology and Transplantation Services in India Science International Award by Giants Group of Ahmedabad.

2009: Doctorate of Sciences” (Honoris Causa) awarded by Honorable Vice President of India,Shri Hamid Ali Ansari at Chhatrapati Shahuji Maharaj University of Lucknow.

Felicitation by Ekta Sports Club of Ahmedabad. “Manav Bhushan” awarded by H.E. Governor of Gujarat, Shri Nawal Kishore

Sharma at Gujarat Divya Jivan Sangh, Sivananda Ashram, Ahmedabad. “Lifetime Achievement Award” for the significant contributions in ‘Nephrology

and Renal Transplantation Teacher’ by the Indian Society of nephrology, 4th December,2009, Guwahati.

Matoshree Santokba Manavratna Award at the hands of Shree Morari Bapu, Surat,Gujarat, India, 28th December, 2009.

2010: Felicitation by Savarkundla Public Social Organisations, 9th May, 2010. Shankaracharya Award for humanitarian services in medical field in presence of H.H.

Swami Jayendra Saraswati of Kanchi Kamakoti peetham, by Hon’ble C.M. ShreeNarendra Modi, Ahmedabad, India, 16th May, 2010

Felicitation by Indian Medical Association – Rajkot Branch, for Continues HumanartarianService Of Kidney Patients 12th September, 2010

Awarded by Giants International, Mumbai in Medicine, 17th September, 2010.

2011: “Shri Kanjibhai Desai Gujarat Pratibha Award” by Vishwa Gujarati Samaj, Ahmedabad,22nd January, 2011.

Felicitation by “Divyabhaasker” newspaper as one of the “100 Most powerful personsof Gujarat” for his development of Nephrology and Transplantation Services in India, 29 th

April, 2011. Felicitated on “Doctors’ Day”, by Sterling Hospital, and by Government Medical College,

Bhavnagar and Sir Takhtasinhji General Hospital, Bhavnagar who jointly organized aBlood Donation Camp in Blood Bank, Sir Takhtasinhji General Hospital for “Rakta-Tula”of Dr. H. L. Trivedi. 1st July, 2011.

IKDRC-ITS awarded as "The Best Single Specialty Hospital-Nephrology-Urology inIndia”, ICICI Lombard & CNBC TV18 India Health Care Awards. New Delhi, 22nd

December, 2011.

9

2012: “NK Patang Gujarat Asmita Award 2012" in Medicine, Ahmedabad, 13th January, 2012. National Achievement Award For Excellence In Medicine (Special Contribution) The

“Image Welfare Achievers Forum” in Mumbai, 14th March, 2012.

“Neelkanth Patang Nagar Pratibha Award” Dharamdev Infrastructure Ltd. and Neelkanth group of Hotels, Ahmedabad at Karnavati Club on 20th May, 2012.

Felicitated on “Doctors’ Day”, by All World Gayatri Pariwar, Vadodara as Pioneer andTrendsetter in the field of Kidney Transplantation. 1st July, 2012.

2013: “The Renny Abraham TANKER Foundation Love for Service Award” by TankerFoundation, Chennai, 25th January, 2013.

IKDRC-ITS- "Best Single Specialty Hospital-Nephrology” in India- ICICI Lombard & CNBC TV18 India Health Care Awards. New Delhi, 9th March, 2013.

‘Gujarat Ratna’ Life for Innovation Award by Gujarat Innovation Society (GISAhmedabad, 15th April, 2013.

2014: “Excellence Award in Health Services”- Year 2012-2013 by Ashirwad Education Trust,Ahmedabad, 8th February, 2014.

Felicitated “Sanskar Choro” by Ahmedabad Municipal Corporation (AMC) 11th Feb.2014.

Felicitation by Aerda Parivar, Shree Leuva Patel Kelavani Mandal Trust, Shree LeuvaPatel Kelavani Mandal Trust, Jain Social Group, Shree Dhoraji Jain SwetamberMurtipujak Tepagachh Sangh, Shree Dasha Shrimali Vanik Chhatralay, Shree DashaShrimali Vanik Gyanti, Shree Sthanakvasi Jain Limbdi Sangh, Hardware AssociationDhoraji and F.M.C.G. Distributors Association, Dhoraji, 6th April, 2014.

ORAL PRESENTATIONS MAINLY RELATED TO TOLERANCE IN ALLOIMMUNITY

AND AUTOIMMUNITY

1. "Donor specific Transfusion and Its Effect on Renal Allograft Survival".1st InternationalCongress on Transplantation and Kidney Diseases. IKDRC, Ahmedabad, India, January5th, 1996.

2. "GM-CSF Stimulated Donor Specific Blood Transfusion and Its Effect on Graft Survival".II International Congress on Transplantation and Kidney Diseases. IKDRC, Ahmedabad,India, January 11th, 1998.

3. "High Dose Donor BMC Associated Tolerance in Live Related Renal AllograftRecipients". VI Congress of Asian Society of Transplantation, Singapore, September.1999.

4. "Tolerance: How We Put The Puzzle Together". III International Congress onTransplantation, Kidney Diseases and Critical Care. IKDRC-ITS, Ahmedabad, India,January, 2000.

5. “DBMC Infusion and Tolerance”. Millennium Oration at Jamnagar Medical College,Gujarat, India, February, 2000.

10

6. "High Dose Donor Bone Marrow Cells (DBMC) Associated Tolerance in Live RelatedRenal Allograft Recipients”. XVIII International Congress of the Transplantation Society,Rome, Italy, August, 2000.

7. Millennium Oration “New Hopes for Live Donor Transplant Patients Experience withTolerance Developments Its Results and Benefits Ahmedabad Experience”. Mumbai,India, 4th March 2001

8. “Successful Treatment of Systemic Lupus Erythematosus (SLE) with Stem CellInoculation In Thymus.”11th International Congress of Immunology, Stockholm, Sweden,26th July, 2001.

9. “Donor Bone Marrow Cell Infusion to Induce Tolerance In Renal Allograft RecipientsAhmedabad Experience”. 20th Annual Meeting of Indian Society of Nephrology, Lucknow,India, September, 2001.

10. “High dose DBMC Infusion Associated Tolerance Ahmedabad Experience”. Dr. R.T. JainMemorial Oration. Indian Society of Nephrology, Annual West Zone Meeting, Vadodara,India, December, 2001.

11. “Allogenic Stem Cell Transplantation in Cutaneous Autoimmunity”. Glaxo DermResearch Forum, Ahmedabad, Gujarat, India, January, 2002

12. “Role of Stem Cell Transplantation In Autoimmune and Alloimmune Disorders”.Rajasthan Kidney Foundation 3rd Annual Meeting, Jaipur, India, February, 2002.

13. “Ahmedabad Experience In Tolerance Induction With Allogeneic Bone Marrow Stem CellInfusion In Renal Transplantation”. Speaker at Plenary Session on Tolerance,7 th Congressof the Asian Society of Transplantation, New Delhi, India, March, 2002.

14. “Megadose Unfractionated Donor Bone Marrow Derived Cell Infusion In Thymus AndPeriphery An Integrated Clinical Approach For Tolerance In Live Related Renal AllograftRecipients”. XIX International Congress of the Transplantation Society, Miami, USA, 26th

August 2002.

15. Panelist on Discussion on “Transplantation without Drugs the Future Agenda”.International Press Conference, Miami, USA, 26th August, 2002.

16. “Stem Cell Transplantation and Alloimmunity”. Transplantation Update 2002, 30th

November, 2002.

17. “Moderator on Panel discussion on Cadaver transplantation”. Transplantation Update2002, 30th November, 2002.

18. “Dysregulation of Self- Tolerance and Stem Cell Transplantation In Symposium OnHematopoietic Stem Cell Transplantation And Autoimmunity”. Transplantation Update2002, Ahmedabad, India, 1st December 2002.

19. “Stem Cell Transplantation Hope for the New Millennium”. Dr. Jal Patel Oration Of TheResearch Society Of Grant Medical College and J.J. Group of Hospitals, Mumbai, India,24th January, 2003.

11

20. “Tolerance Induction with Allogeneic Stem Cell Transplantation Myth Or Reality?”.Special Guest Lecture On The Occasion Of Foundation Day Of Institute OfImmunohematology (ICMR), Mumbai, India, 4th February, 2003.

21. “Renal Transplantation New Concept Drugless Management” – Dr. S. K. Pande MemorialOration, Jodhpur, India, 12th February, 2003.

22. “Hematopoeitic Stem Cell Transplantation Induced Allograft Tolerance AhmedabadExperience”. Oration, Jaipur, 24th January, 2004.

23. “Allogenic Stem Cell Transplantation, Mixed Hematopoietic Chimerism in RenalTransplantation”, Oration, S.G.P.G.I., Lucknow, 7th June, 2004.

24. “Medawar Mouse - A Journey from London to Ahmedabad”. Inaugural oration at NizamInstitute of Medical Sciences, Hyderabad. 24th September, 2004.

25. “Medawar Mouse – A journey from London to Ahmedabad”. Oration at AhmedabadAssociation of Pathologists and Microbiologists, Ahmedabad. 17th October, 2004.

26. “Transplantation Tolerance with Natural Suppressor Cell Chimerism in Living RelatedDonor Renal Allograft Recipients”. American Transplant Congress, Seattle, Washington,USA 25th May, 2005

27. “Mixed Allogenic Suppressor And Stem Cell Chimerism Associated Tolerance In Renal Transplantation”. 3rd World Congress of Nephrology, Singapore, 27th June, 2005.

28. “Mixed Allogeneic Natural Suppressor and Stem Cell Chimerism Associated Tolerance InRenal Transplantation”. Seoul National University, Seoul, Korea, 14th July, 2005.

29. The Association of Physiologists and Pharmacologists of India, Ahmedabad Chapter forhis Extraordinary Presentation On The Subject of “The Stem Cell, Medical Miracle toMankind” on the Teacher’s Day. 5th September, 2005.

30. "Transplantation Tolerance Using Adult HSC in Renal Allograft Recipients - Ahmedabadexperience" Oration at Banaras Hindu University, 40th Anniversary of KidneyTransplantation, National Symposium on Preventive Nephrology and Kidney Week,Kidney Research Foundation, Department of Nephrology and Urology, Institute ofMedical Sciences, BHU, Varanasi, 6th October, 2005.

31. “Autoimmunity and Renal Diseases”. CME on Renal Disorders, 11th November, 2005.

32. “Experience of Stem Cell Transplantation as a Modulator of Allo-Immunity: JourneyFrom Adult To Embryo”. IV International Congress on Kidney Disease, 13th November,2005.

33. “Embryonic Stem Cells Immortalizing The Mortals! Ahmedabad Experience”. Indo- USAnd TF Symposium on Neonatal and Fetal Surgical Anomalies and Role of Stem CellTransplantation. Institute of Medical Sciences, BHU, Varanasi, 14th February, 2006.

34. “Immunobiology of Rejection and Adaptation”. CME in Renal and TransplantationPathology, Stem Cell Transplantation and Preventive Nephrology, Ahmedabad, 4th

October, 2006.

12

35. “Mixed Hematopoietic Chimerism Associated T-B Cell Tolerance”. CME in Renal andTransplantation Pathology, Stem Cell Transplantation and Preventive Nephrology,Ahmedabad, 5th October, 2006.

36. “In pursuit of the Ultimate - Ahmedabad Journey To Transplantation Tolerance”. XVIIAnnual Conference Of Indian Society of Organ Transplantation, Ahmedabad, 6th October,2006.

37. “Stem Cell Transplantation and Tolerance”. 37th Annual Conference Of The Indian SocietyOf Nephrology, Bhubaneshwar, 1st December, 2006.

38. “Ahmedabad Experience of Tolerance Induction in Renal Transplantation”. AnnualConference of Indian Society of Nephrology, West Zone Chapter, Chhattisgarh, India, 21st

September, 2007.

39. “Identification and Management of Hyper-Responders: New Insight In TransplantationImmunology”. Transplantation Update, Ahmedabad, 1st December, 2007.

40. “Stem Cells and Transplantation Tolerance”. Oration at Stanley Medical College, Chennai,2nd February, 2008.

41. “A New Protocol of Clonal Deletion and Allogeneic Stem Cell Transplantation With NoPost-Transplant Immunosuppression In Living Related Donor Renal Transplantation”.Sydney, Australia, 11th August, 2008.

42. “Ubiquitin-Proteasome Inhibition In Transplantation Immunobiology”. Indian Society ofNephrology, West Zone Chapter, Gandhinagar, Guest lecture, 27th September, 2008.

43. “Stem Cell Transplantation In Lupus Nephritis”. Transplantation Update, Ahmedabad, 9th

January, 2009.

44. John Dossetor Oration “Proteasome Inhibitor Bortezomib, the Hero of Tolerance Saga”.Transplantation Update, Ahmedabad, 10th January, 2009.

45. “Stem Cell Transplantation in IDDM Ahmedabad Experience”. Transplantation Update,Ahmedabad, 11th January, 2009.

46. Main Speaker of Workshop on “Immune Tolerance in Renal Transplantation”.Transplantation Update 2009, IKDRC-ITS, Ahmedabad, 10th January, 2009.

47. “Pre-Transplant Clonal Deletion Allows for HLA Mismatched Renal TransplantationWithout Maintenance Immunosuppression”. American Transplant Congress, Boston, MA,May 31st, 2009.

48. “Bortezomib the Hero of Saga Transplant Tolerance”. 40th Annual Conference of theIndian Society of Nephrology, Guwahati, 4th December, 2009.

49. “Tolerance Vaccine- Where Are We?”. Transplantation Update 2010, IKDRC-ITS,Ahmedabad, 12th February, 2010.

50. “Bortezomib in transplantation tolerance”. Transplantation Update 2010, IKDRC-ITS,Ahmedabad, 13th February, 2010.

13

51. “Stem Cell Immunobiology and Transplantation - Professors’ Outlook”. Lecture andConducted Interactive PG Teaching On Telecommunications For Nephrology Students OfIndia, Conducted by Zydus Ltd., Ahmedabad, 12th June 2010.

52. “Deceased Donor Organ Transplantation At IKDRC-ITS-Where Do We Stand?” ISNWZ-2010, Surat, India, 18th September, 2010.

53. “Journey to the Promised Land of Transplantation Tolerance: Ahmedabad Experience”.Transplantation Update 2011, IKDRC-ITS, Ahmedabad, 8th January, 2011.

54. “The Growth of Cadaver Transplantation in Gujarat” Sterling Hospital, Bhavnagar, 1st

July, 2011.

55. “Antibody Mediated Rejection As We Understand Today”. 12th Congress of the AsianSociety of Transplantation (CAST) Seoul, Korea, 25th September, 2011.

56. “Success Story of Millennium - Transplantation Tolerance”. All World Gayatri Pariwar,Vadodara, 1st July, 2012.

57. “Co-Transplantation of Donor Stem Cells with Kidney Leads to Clinical ToleranceAssociated With Clonal Deletion and T-Regulatory Cell Generation” 24th InternationalCongress of The Transplantation Society, Berlin, Germany, 18th July, 2012.

58. “Six Decades of Transplantation: The Road to Tolerance” Transplantation Update 2012,IKDRC- ITS, Ahmedabad, 28th September, 2012.

59. “Living Donor Renal Transplantation with Low Dose Steroid Monotherapy Using StemCell Transplantation Associated With Generation of Regulatory T-Cells” TransplantationUpdate 2012, IKDRC-ITS, Ahmedabad, 29th September, 2012.

60. “Regulatory T-Cell Generation from Mesenchymal Stem Cells: Gateway to TransplantTolerance” Ganpat University, Kherva 28th December, 2012.

61. “A Journey to the Lesser Travelled Road of Transplant Tolerance” Sri RamachandraUniversity, Chennai, 24th January, 2013.

62. “Pre-transplant Infusion of Donor Stem Cells Opens Gateway to Tolerance AssociatedWith Induction of Regulatory T-Cells - Single Centre Experience In Living Donor Renal Transplantation”.12th Congress of the Cell Transplant Society, Milan, Italy, 7th July, 2013.

63. “Pre-Transplant Donor Stem Cell Infusion Leads To Clinical Tolerance In Living Donor Renal Allograft Recipients” 13th Congress of the Asian Society of Transplantation 2013 (CAST 2013) Kyoto, Japan, 3rd September, 2013.

64. “Regulatory T-cells for Induction and Sustenance of Transplant Tolerance”Transplantation Update 2013, IKDRC-ITS, Ahmedabad, 18th October, 2013.

65. “Stem Cell Therapy and Renal Transplantation for Diabetic Nephropathy Induced ESRD-Success and Challenges” Transplantation Update 2013, IKDRC-ITS, Ahmedabad, 19th

October, 2013.66. “Regulatory T-Cells Support Stem Cell Therapy In Safe Minimization Of

Immunosuppression In Living Donor Renal Transplantation: Initial Single CentreExperience” 51st ERA-EDTA Congress, Amsterdam, 3rd June, 2014.

14

POSTER PRESENTATION: 1. Stem Cell Therapy Protects The Renal Allograft From Immune Injury Single Centre

Experience. 51st ERA-EDTA Congress, Amsterdam, 1st June, 2014.

PUBLICATIONS

1. Trivedi HL. Mallory-Weiss syndrome with haemothorax. J Indian Med Assoc. 1966 Aug16;47(4):187-8.

2. Browner J, Trivedi HL. Sataline LR. Haemocholecyst report of a case associated withanticoagulation therapy. The Ohio Sate Medical Journal 1966; 62(10): 1028-30.

3. Shimizu A, Trivedi HL. Thompson GD. Straight arteriovenous shunt for long termhemodialysis. Journal of the American Medical Associations. 1971; 216(4): 645-47.

4. Haberstro B, Uniyal B, Trivedi HL. A clot screw dialysis transplantation journal 1974;3(1): 27

5. Kaegi A, Pineo GF, Shimizu A, Trivedi HL, Hirsh J, Gent M. Arteriovenous shuntthrombosis prevention by sulfinpyrazone. N Engl J Med. 1974;290(6):304-6..

6. Trivedi HL. Letter: Iliacus hematoma syndrome, Can Med Assoc J. 1975;113(1):16-9

7. Kasgi A, Pineo G, Shimisu A, Trivedi HL. The role of sulfinpyrazone in the prevention ofarterio-venous shunt thrombosis. Circulation. 1975; 52: 497-99.

8. Kumar S, Trivedi HL, Smith E. Carpal tunnel syndrome: a complication of arteriovenousfistula in hemodialysis patients. Can Med Assoc J. 1975; 113(11-12):1070-72.

9. Trivedi HL. No exam - compact revolutionary model for undergraduate medicaleducation. Mc Master Model. Indian Journal of Medicine, 1976; 4(1):1-2.

10. Trivedi HL, Kumar S, Kelly J. Commentary on article “Septicemia: a legal pitfall inhemodialysis” Dialysis and Transplantation, 1976; 5(4): 81.

11. Trivedi HL, Kumar S. Letter to the editor, Renal Transplantation in lethal disease Annualof Internal Medicine, 1976; 85(1): 132.

12. Kumar S, Trivedi HL, Smith E. Letter: Rhinocerebral mucor mycosis in a renal transplantpatient. J Oral Surg. 1976; 34(7): 583.

13. Kumar S, Mehta J, Trivedi HL. Light-chain proteinuria and reversible renal failure inrifampin-treated patients with tuberculosis. Chest. 1976; 70(4): 564-65.

14. Trivedi HL, Kumar S, Minielly J. Renal cortical micro-abscess as cause of reversibleacute renal failure. Urology. 1977; 9(2):177-79.

15. Trivedi HL. Cricket and kidney. Indian Journal of Nephrology, 1985; 1.

15

16. Trivedi HL. New Frontiers and new hopes. Indian Journal of nephrology, 1985; 1(1):1-2.

17. Trivedi HL. Charak as a nephrologist. Indian Journal of Nephrology, 1985;1:1.

18. Trivedi. HL. Antibodies to DNA in the diagnosis of systemic lupus erythematosusIndian Journal of Nephrology, 1985;1:1.

19. Trivedi HL. Bacteriuria. Indian Journal of Nephrology, 1985;1(1):35-38.

20. Trivedi HL. Life after death. Indian Journal of Nephrology, 1985; 1:39.

21. Trivedi HL. Donor specific transfusion and its implications on renal transplantation inIndia, Indian Journal of nephrology, 1985;1: 41-42.

22. Trivedi HL. Urinary Tract Infection. Indian Journal of Nephrology, 1985; 1(3-4): 85-86.

23. Prajapati B, Sharma RK, Joshi V, Shah PR, Shah PP, Trivedi HL. Prune Belly syndrome:A case report and review of literature. Indian journal of Nephrology, 1985; 1(3-4): 108-110.

24. Sharma RK, Trivedi HL, Shah PP. Slow Intravenous diazoxide in the management ofmalignant hypertension with severe renal failure. Indian Journal of Nephrology, 1985; 1 (3-4): 116-118.

25. Trivedi HL. Human lymphocytes the knight of the chess game of Immunobiology. IndianJournal of Nephrology, 1986; 2:1-2.

26. Trivedi HL. Kidney and Heart failure. Indian Journal of Nephrology, 1986; 2(3): 1-2.

27. Trivedi HL. Pregnancy kidney and urinary infections. Indian Journal of Nephrology,1986; 2(3): 67-69.

28. Trivedi HL. Management of Chronic renal failure in India perspective. Indian Journal ofNephrology, 1986; 2(3): 70.

29. Trivedi HL. Peritoneal dialysis past, present and future. Indian Journal of nephrology,1986; 2(3): 99-101.

30. Sharma RK, Mishra VV, Pancholy S, Vyas K, Trivedi HL. Growth of clinical bacterialisolates in used and unused peritoneal dialysis fluid. Indian Journal of Nephrology, 1986;2(4): 118-121.

31. Kadakia P, Desai NT, Shah PP, Shah PR, Chakraborty S, Pandey S, Asari A, Joshi MN,Trivedi HL. Oral lesions in chronic renal failure (Clinical and radiological evaluation).Indian Journal of Nephrology, 1986; 2(4): 135-139.

32. Trivedi HL. New perspective in immunopathology of glomerulonephritis. Indian Journalof Nephrology, 1987; 3(1): 1-3.

33. Trivedi HL. Immunosuppressive treatment as a therapeutic modality for real transplantrecipients, Indian Journal of Nephrology, 1987; 3(3): 35-37.

16

34. Sharma RK, Mishra VV, Joshi B, Mehta MN, Dave MP, Trivedi HL. Glycosylatedhemoglobin levels in C R F. Indian Journal of Nephrology, 1987; 3 (3): 57-61.

35. Trivedi HL, Shah PP, Vyas K. An open prospective randomised, comparative trial ofampicillin vs Co-trimoxazole (Septran) in acute uncomplicated urinary tract infection. IndianJournal of Nephrology, 1987; 3(2): 74-80.

36. Trivedi HL. Cadaveric transplantation in India. Indian Journal of Nephrology, 1987; 3(3):81-83.

37. Trivedi HL, Cyclosporine – New hope for transplants. Indian Journal of Nephrology,1987; 3(3):1.

38. Trivedi HL, Patel SM, Shah VR, et al. A case report, successful renal transplantation withkidney from a cadaver donor soon after his clinical death. Indian Journal of Nephrology,1987; 3(3): 113-116.

39. Trivedi HL. Natriuretic hormones. Indian Journal of Nephrology, 1988; 4(1): 1-3.

40. Motiwala HG, Joshi V, Trivedi HL. Matrix calculi: Derivation & management. IndianJournal of Nephrology, 1988; 4(1): 12-20.

41. Trivedi HL. Uraemic acidosis. Indian Journal of Nephrology, 1988; 4(2): 77-79.

42. Zope J, Barjatiya M, Shah PR, Shah PP, Trivedi HL. Indian Journal of Nephrology, 1988;4(3-4): 110-14.

43. Trivedi HL. Physiology of diuretic action. Indian Journal of Nephrology, 1988; 4(3-4):119-12.

44. Barjatiya M, Dave S, Shah PR, Shah PP, Trivedi HL. Renal and external manifestationsof tuberous sclerosis. Indian Journal of Nephrology, 1988; 4(3-4): 128-37.

45. Joshi B, Asari A, Pandya C, Sharma RK, Trivedi HL, et al. Effect of occupationalexposure of cadmium on renal functions of unorganized factory workers. Indian Journal ofNephrology, 1988; 4(3-4): 151-59.

46. Barjatiya MK, Shah NK, Kothari SS, Shah PP, Trivedi HL. Spontaneous left ventriclecavity thrombus in a patient of systemic lupus erythematosus. J Assoc Physicians India.1992; 40(3):195-96.

47. Sathaye UV, Shah PR, Bhargava PA, Sathaye AU, Trivedi HL. Vesico-ureteric reflux in agrafted kidney as a cause of massive hematuria: a case report. Nephron 1993; 64(3): 476.

48. Rajbala A, Sane AS, Zope J, Mishra VV, Trivedi HL. Oxidative stress status in childrenwith nephrotic syndrome. Pan Minerva Med. 1997; 39(3):165-68.

49. Rajbala A, Sane AS, Shah PR, Mishra VV, Patel SM, Shah SA, Shah VR, Trivedi HL.Effect of renal transplantation (surgical stress) on serum levels of oxidants and reducingsystem. Pan Minerva Med. 1999; 41(1): 31-4.

50. Trivedi HL, Shah VR, Shah PR, Shah SA, Shah T, Pancholi N, Visana K, Vanikar AV,Trivedi VB, Darji P, Patel H, Sane AS. GM-CSF Stimulated Donor Bone Marrow Derived

17

Cell (BMDC) infusion to enhance allograft survival in living donor renal allograft recipients;Transplantation India 1999; 1(1): 3-7.

51. Rajbala A, Sane AS, Upadhyay AR, Mishra VV, Trivedi HL. Iodinated contrast mediainduced oxidative stress status in patients undergoing urography. Pan Minerva Med. 2000;42(2):119-22.

52. Bela P, Bahl R. Sane AS, Sawant PH, Shah VR, Mishra VV, Trivedi HL. Oxidative stressstatus: possible guideline for clinical management of critically ill patients. Pan Minerva Med.2001; 43(1):27-31.

53. Trivedi HL, Shah VR, Shah P, Darji P, Sane AS, Vanikar AV, Trivedi HL, Savani H,Narayanan K, Velusami S, Dalal S, Shah SA, Shah, Pancholi N, Visana K. High dose DBMCassociated tolerance in live-related renal allograft recipients; Transplant-Proc. 2000; 32(7):2001-2.

54. Trivedi HL, Shah VR, Shah PR, Sane AS, Vanikar AV, Trivedi VB, Velusami S,Narayanan K, Dalal SS, Pancholy NC, Shah SA, Shah TP, Visana KV. Megadose approachto DBMC infusion-induced allograft hypo-responsiveness in living-related renal allograftrecipients; Transplant-Proc. 2001; 33(1-2): 71-6.

55. Shukla KD, Khemchandani SK, John PJ, Ranka P, Chaudhary R, Trivedi HL. Thedomino procedure: a new phase in the saga of kidney transplantation in India. TransplantProc. 2002; 34(4):1143-44.

56. Trivedi HL, Shah VR, Vanikar AV, Gera DN, Shah PR, Trivedi VB, Khemchandani SI,Mehta A, Dalal SS, Shah SA, Shah TP, Visana KV. High-dose peripheral blood stem cellinfusion: A strategy to induce donor-specific hypo-responsiveness to allografts in pediatricrenal transplant recipients. Pediatric Transplantation, 2002; 6(1): 63-8.

57. Trivedi HL. Mini bone marrow transplantation as an adjuvant therapy to induce tolerancein clinic: Ahmedabad experience; Transplantation India, 2002; 1(1): 3-4. (Editorial)

58. Trivedi HL, Vanikar AV, Modi PR, Thaker P, Parekh A, Patel RD, Kanodia KV, Shah VR,Trivedi VB. Intrathymic donor- antigen inoculation and megadose peripheral hematopoieticstem cell infusion in live-related renal allograft transplantation – a strategy to inducetolerance in clinic; Transplantation India, 2002; 1(1): 32-9.

59. Trivedi HL. Allogeneic hematopoietic stem cell transplantation – a novel approach fortreatment of pemphigus vulgaris, Transplantation India, 2002; 1(1): 40-3.

60. Trivedi HL. Hemopoietic stem cell transplantation in clinical practice, Glimpses ofMedicine 2003; 5: 20-2.

61. Trivedi HL, Vanikar AV, Shah VR, Mehta A, Shah SA, Shah T, Visana K, Modi PR,Sinha P, Trivedi VB. Mega dose un-fractionated donor bone marrow-derived cell infusion inthymus and periphery: An integrated clinical approach for tolerance in living related renalallografts, Transplant-Proc. 2003; 35(2): 203-06.

62. Trivedi HL. Destination: Tolerance in Clinic; Transplantation India, 2003; 2(1): 1-2.

63. Trivedi HL, Vanikar AV, Shah VR, Modi PR, Viroja D, Trivedi VB. Donor hematopoieticstem cell infusion in thymus and periphery : An integrated approach to achieve tolerance in

18

cadaver renal allograft recipients- HSC infusion in cadaver renal transplantation,Transplantation India, 2003; 2(1): 30-4.

64. Trivedi HL, Mixed allogeneic chimerism and Transplantation Tolerance; TransplantationIndia, 2004; 3(1): 1.

65. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil J, Trivedi VB. Our experience oftolerance induction in paediatric renal allograft recipients with living related donors,Transplantation India, 2004; 3(1): 26-8.

66. Trivedi HL. First two decades of cyclosporine era in clinical transplantation from atransplant physician’s diary. Transplantation India, 2004; 3(2): 1-2.

67. Trivedi HL. Immunobiology of allogenic hematopoietic stem cell transplantation,Transplantation India, 2004; 3(2): 3-5.

68. Trivedi HL. Allogeneic stem cell transplantation mixed hematopoietic chimerism andtolerance: Five years experience with renal transplantation, Transplantation India, 2004; 3(2):17-3.

69. Trivedi HL, Vanikar AV, Vakil JM, Shah VR, Modi PR, Trivedi VB. A strategy to achievedonor-specific hypo-responsiveness in cadaver renal allograft recipients by donorhaematopoietic stem cell transplantation into the thymus and periphery. Nephrol. Dial.Transplant. 2004; 19(9): 2374-77.

70. Trivedi HL. Medawar mouse visits Ahmedabad! Transplantation India, 2004; 3(3) :1-3.

71. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.Allogeneic hematopoietic stem cell transplantation, mixed chimerism and tolerance in livingrelated donor renal allograft recipients. Transplantation India, 2004; 3(3): 8-13.

72. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SIAllogeneic hematopoietic stem cell transplantation, mixed chimerism and tolerance in livingrelated donor renal allograft recipients. Transplant Proc; 2005; 37; 737-42.

73. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Khemchandani SI, Vakil JM, Trivedi VB,Patel RD. Classical tolerance induction in renal transplantation- A study of 11 patients. HongKong J Nephrol; 2005; 7(1): 27-33.

74. Vanikar AV, Trivedi HL, Patel RD, Kanodia KV, Vakil JM. Effects of tolerance inductionprotocol in renal allograft recipients- the Ahmedabad experience. Hong Kong J Nephrol,2005; 7(1): 22-26.

75. Trivedi HL. Post transplant ischemia reperfusion injury, innate immunity and allograftrejection. Transplantation India, 2005; 4(1):1.

76. Trivedi HL. Natural suppressor cell biology and its relevance to “tolerance” in renaltransplantation. Transplantation India, 2005; 4(1): 2-4.

77. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Khemchandani SI, Batra V, Shah PR,Trivedi VB. Transplantation tolerance with natural suppressor cell chimerism in livingrelated donor renal allograft recipients- Ahmedabad experience. Transplantation India, 2005;4(1):17-24.

19

78. Trivedi HL. The First 25 Years – Years of faith, fights and fulfillment! TransplantationIndia 2005; 4(2) 1-2.

79. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Khemchandani SI, Shah VP, Trivedi VB,Batra V. Allogeneic hematopoietic stem cell transplantation induced mixed chimerism acrossMHC barriers can achieve prope tolerance in living related renal transplantation: Ahmedabadexperience. Transplantation India 2005; 4(2): 7-13.

80. Vanikar AV, Trivedi HL, Potnis S. De novo acute hemolytic uremic syndrome in a renalallograft recipient associated with Sirolimus administration- A case report. TransplantationIndia 2005; 4(2): 19 -21.

81. Trivedi HL, Mishra VV, Vanikar AV, Modi PR, Shah VR, Shah PR, Feroz A. Embryonicstem cell derived and adult hematopoietic stem cell transplantation for tolerance induction inrenal allograft recipients – A case report. Transplant Proc. 2006; 38 (9): 3103-08.

82. Trivedi HL. Transplantationology takes the center stage in Indian medicine. TransplantProc. 2007; 39(3): 643.

83. Trivedi HL. Immunobiology of rejection and adaptation. Transplant Proc. 2007; 39(3):647-52.

84. Trivedi HL, Vanikar AV, Modi PR, Shah PR, Shah VR, Trivedi VB. In pursuit of theultimate: the initial Ahmedabad journey towards transplantation tolerance. Transplant Proc.2007; 39(3) 653-57.

85. Vanikar AV, Trivedi HL. Chronic rejection: An enduring enigma of transplantationbiology, Transplant Proc. 2007; 39(3): 773-78.

86. AV Vanikar, Modi PR, Patel RD, Kanodia KV, Shah VR, Trivedi VB, Trivedi HL.Hematopoietic stem cell transplantation in autoimmune diseases: the Ahmedabad experience.Transplant Proc. 2007; 39(3): 703-08.

87. Vanikar AV, Mishra VV, Feroz A, Shah VR, Dave SD, Patel RD, Kanodia KV, Patel J,Patel C, Trivedi HL. Successful generation of donor specific hematopoietic stem cell linesfrom co-cultured bone marrow with human embryonic stem cell line: a new methodology.Transplant Proc. 2007; 39(3): 658-61.

88. Feroz A, Dabhi M, Gumber MR, Gupta S, Shah PR, Rizvi SJ, Modi PR, Shah SA,Khemchandani SI, Bhandari NS, Bhosale GP, Shah VR, Trivedi VB, Dave AP, Dave JM,Trivedi HL. Cadaveric renal transplantation: Our experience at the Institute of KidneyDiseases & Research Centre, Institute of Transplantation Sciences, Ahmedabad. TransplantProc. 2007; 39(3): 721-22

89. Modi PR, Shah VR, Vanikar AV, Trivedi HL. Impact of retroperitoneoscopic donornephrectomy on renal allograft in Indian and African recipients. Transplant Proc. 2007;39(3): 723-25.

90. Trivedi HL, Vanikar AV. Hematopoietic stem cell transplantation and auto immunity -Ahmedabad experience, Vak Biotechnology 2007; 2: 23-34.

20

91. Trivedi HL, Doshi GR, Mehta KM. Preface. (Editorial) Transplant Proc. 2008;40(4):1083.

92. Saboo D, Shah PR, Goplani KR, Feroz A, Gumber MR, Vanikar AV, Trivedi HL.Posttransplant diabetes mellitus: a single-center study. Transplant Proc. 2008; 40(4): 1111-3.

93. Goplani KR, Vanikar AV, Shah PR, Gumber M, Feroz A, Patel HV, Kasat P, Falodia J,Saboo D, Kaswaan K, Geerish MS, Pandya T, Trivedi HL. Post-renal transplant hemolyticuremic syndrome/thrombotic microangiopathy: Ahmedabad experience. Transplant Proc.2008; 40(4):1114-16.

94. Trivedi HL, Vanikar AV, Thakker UG, Firoze A, Dave SD, Patel CN, Patel JV, BhargavaAB, Shankar V. Human adipose tissue-derived mesenchymal stem cells combined withhematopoietic stem cell transplantation synthesize insulin. Transplant Proc. 2008; 40(4):1135-39.

95. Kanodia KV, Vanikar AV, Goplani KR, Gupta SB, Trivedi HL. Sickle cell nephropathywith diffuse proliferative lupus nephritis: a case report. Diagn Pathol. 2008; 28; 3(1): 3-9.

96. Suthar KS, Vanikar AV, Trivedi HL. Renal transplantation in primary focal segmentalglomerulosclerosis using a tolerance induction protocol. Transplant Proc. 2008; 40(4): 1108-10.

97. Kanodia KV, Vanikar AV, Trivedi HL. Study of acute antibody-mediated rejection in renalallograft biopsies. Transplant Proc. 2008; 40(4): 1099-103.

98. Mehta T, Feroz A, Thakkar UG, Vanikar AV, Shah VR, Trivedi HL. Subarachnoidplacement of stem cells in neurological disorders. Transplant Proc. 2008; 40(4):1145-7.

99. Kanodia KV, Vanikar AV, Patel RD, Shah PR, Nagpal M, Firoz A, Falodia J, Kasat P,Trivedi HL. De novo collapsing glomerulopathy in a renal allograft recipient, Saudi JKidney Dis Transpl. 2008;19(5):793-5.

100. Kaneku H, Idica A, Everly MJ, Terasaki PI, Feroz A, Vanikar AV, Shankar V, Trivedi VB,Modi PR, Khemchandani SI, Dave SD, Trivedi HL. Editor by J. Michael Cecka & Paul I.Terasaki and Published by Terasaki Foundation Laboratory, California. “Donor- specificHLA antibody response in clonal deletion”. Chapter in Text Book Named ‘ClinicalTransplants 2008’, 189-197p. (Chapter 18)

101. Idica A, Kaneku H, Everly MJ, Trivedi HL, Feroz A, Vanikar AV, Shankar V, Trivedi VB,Modi PR, Khemchandani SI, Dave SD, Terasaki PI. Editor by J. Michael Cecka & Paul I.Terasaki and Published by Terasaki Foundation Laboratory, California. “Elimination of Post-transplant donor-specific HLA antibodies with bortezomib”. Chapter in Text Book Named‘Clinical Transplants 2008’. 229-239p. (Chapter 21)

102. Patel RD, Vanikar AV, Feroze A, Shah PR, Trivedi HL. Ahmedabad tolerance inductionprotocol and chronic renal allograft dysfunction: pathologic observations and clinicalimplications. Diagn Pathol. 2009; 4(1): 4.

103. Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB,Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD. Abrogation of anti-hlaantibodies via proteasome inhibition. Transplantation 2009; 87(10):1555-61.

21

104. Aziz F, Pandya T, Patel HV, Ramakrishna P, Goplani KR, Gumber M, Vanikar AV,Kanodia K, Shah PR, Trivedi HL Nephrotic presentation in hydatid cyst disease withpredominant tubulointerstital disease: Case Report. Int J Nephrol Renovasc Dis. 2009;2:23-6

105. KV Kanodia, Vanikar AV, Goplani KR, Trivedi HL. Diabetic nephropathy with crescenticGN. Saudi J Kidney Dis Transpl. 2009; 20(4): 672-73.

106. Mohapatra N, Vanikar AV, Patel RD, Trivedi HL. Modifying cyclosporine associatedrenal allograft dysfunction. Saudi J Kidney Dis Transpl. 2009; 20(5): 770-74.

107. Modi PR, Rizvi SJ, Trivedi HL. Successful en bloc transplantation of pediatric deceaseddonor kidneys with grade 1 injury. Indian J Nephrol 2009; 19(4):167-69.

108. Goplani KR, Firoz A, Ramakrishana P, Shah PR, Gumber MR, Patel HV, Vanikar AV,Trivedi HL. Deceased donor organ transplantation with expanded criteria donors: A singlecenter experience from India, Transplant Proc. 2010; 42(1): 171-74.

109. Trivedi HL, Terasaki PI, Feroz A, Vanikar AV, Trivedi VB, Khemchandani SI, Dave SD,Shankar V, Modi PR, Kaneku H, Idica A, Everly MJ. Clonal deletion with bortezomibfollowed by low or no maintenance immunosuppression in renal allograft recipients.Transplantation. 2010; 90(2):221-2.

110. Kute VB, Godara SM, Goplani KR, Gumber MR, Shah PR, Vanikar AV, Shah VR,Trivedi HL. High mortality in critically ill patients infected with 2009 pandemic influenza a(H1N1) with pneumonia and acute kidney injury. Saudi J Kidney Dis Transplant2011;22(1):83-89

111. Everly MJ, Terasaki PI, Hopfield J, Trivedi HL, Kaneku H. Protective immunity remainsintact after antibody removal by means of proteasome inhibition. Transplantation 2010;90:1493–1498.

112. Goplani KR, Kute VB, Vanikar AV, Shah PR, Gumber MR, Patel HV, Modi PR, TrivediHL. Expanded criteria donor kidneys for younger recipients: Acceptable outcomes.Transplant Proc. 2010; 42(10):3931-4.

113. Kute VB, Goplani KR, Godara SM, Shah PR, Vanikar AV, Trivedi HL. Post-exposureprophylaxis for H1N1 with oseltamivir in renal allograft recipent - safe and effective withoutany immunosuppressive drug interaction. J Assoc Physicians India 2011; 59(1): 49-51.

114. Vanikar AV, Dave SD, Thakkar UG, Trivedi HL. cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: A noveltherapy for insulin-dependent diabetes mellitus, Stem Cells Int. 2010 Dec 20; 2010:582382.

115. Vanikar AV, Shah PR, HL. Trivedi, Letter to the Editor -B.K. polyoma virus nephropathyin renal allograft recipient, Saudi J Kidney Dis Transplant 2011; 22(1):136-138.

116. Vanikar AV, Trivedi HL, A. Feroze, KV Kanodia, SD Dave, Shah PR, Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared tohematopoietic stem cell transplantation alone in renal transplantation to achieve donorhyporesponsiveness. Int Urol Nephrol. 2011; 43(1): 225-32.

22

117. Kute VB, Vanikar AV, Trivedi HL, Shah PR, KR Goplani, Gumber MR, Patel HV, SMGodara, Modi PR, Shah VR. Outcome of renal transplantation in patients with diabeticnephropathy : A single-center experience. Int Urol Nephrol. 2011; 43(2): 535-41.

118. Vanikar AV, KR Goplani, A. Feroz, KV Kanodia, Patel RD, KS Suthar, Patel HV, GumberMR, Shah PR, Trivedi HL. Operational tolerance in living-related renal transplantation: Asingle-center experience. Transplant Proc. 2011: 43(5): 1551-58.

119. Gumber MR, Kute VB, KR Goplani, Shah PR, Patel HV, Vanikar AV, TP Pandya, HLTrivedi. Transplantation with kidney paired donation to increase the donor pool: A single-center experience. Transplant Proc. 2011; 43(5): 1412-14.

120. Trivedi HL, UG Thakkar, AV Vanikar, SD Dave, Treatment of polyglandularautoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymalstem cells and haematopoietic stem cells. BMJ Case Reports published online 5 September2011.

121. Shah PR, Kute VB, DS Saboo, KR Goplani, Gumber MR, Vanikar AV, Patel HV, HLTrivedi. Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensinreceptor blockers in chronic allograft injury. Saudi J Kidney Dis Transpl 2011; 22(6): 1128-32.

122. Shah PR, Vanikar AV, Gumber MR, Patel HV, Kute VB, SM Godara, Trivedi HL. Renaltransplantation in hepatitis C positive patients: A single centre experience, J Transplant. 2011;2011:581485.

123. Kute VB, SM Godara, Shah PR, SH Jain, DP Engineer, Patel HV, Gumber MR, BCMunjappa, VV Sainaresh, Vanikar AV, Modi PR, Shah VR, Trivedi HL. Outcome ofdeceased donor renal transplantation in diabetic nephropathy: A single-center experiencefrom a developing country. Int Urol Nephrol. 2012;44(1):269-74.

124. MJ Everly, PI TerasakiI, Trivedi HL. Durability of antibody removal followingproteasome inhibitor-based therapy. Transplantation. 2012; 93(6):572-7.

125. Trivedi HL, Vanikar AV, Gumber MR, Patel HV, Shah PR, Kute VB. Abrogation ofantibodies improves outcome of renal transplantation, Transplant Proc. 2012; 44(1): 241-47.

126. Shah PR, Modi PR, Kute VB, Vanikar AV, Patel HV, Gumber MR, Shah VR, HL Trivedi.World kidney day 2010: Medical aspects of 10 live-donor renal transplantations in a singlecenter from a developing country. Transplant Proc. 2012; 44(1): 47-8.

127. Gumber MR, Kute VB, KR Goplani, Vanikar AV, Shah PR, Patel HV, Trivedi HL.Outcome of renal transplantation in Alport's syndrome: A single-center experience,Transplant Proc. 2012; 44(1): 261-63.

128. Patel HV, Kute VB, Vanikar AV, Shah PR, Gumber MR, SH Jain, DP Engineer, GHGhelani, Trivedi HL. Clinical outcome of renal transplantation in end-stage renal diseasepatients With positive pretransplantation hepatitis B surface antigen. Transplant Proc. 2012;44(1): 72-4.

129. AV Vanikar, KV Kanodia, RD Patel, KS Suthar, HV Patel, MR Gumber, HLTrivedi. IgM nephropathy in India: A single centre experience. Indian J Pediatr. 2012; 79(8): 1025-7.

23

130. Vanikar AV, Trivedi HL, Patel RD, KV Kanodia, Modi PR, Shah VR. Allogenichematopoietic stem cell transplantation in pemphigus vulgaris: A single-center experience.Indian J Dermatol 2012; 57(1): 9-11.

131. SD Dave, Vanikar AV, Trivedi HL. Ex vivo generation of glucose sensitive insulin secreting mesenchymal stem cells derived from human adipose tissue. Indian J Endocr Metab 2012; 16: S65-9.

132. Kute VB, Vanikar AV, Shah PR, Gumber MR, Patel HV, SM Godara, BC Munjappa, VV Sainaresh, DP Engineer, SH Jain, Modi PR, Shah VR, Trivedi VB, Trivedi HL. Post renal transplant cytomegalovirus infection: study of risk factors. Transplant Proc. 2012; 44 (3):706-9.

133. Kute VB, HL Trivedi, Vanikar AV, Shah PR, Gumber MR, Patel HV, JG Goswami, KV Kanodia. Plasmodium vivax Malaria-associated Acute Kidney Injury, India, 2010-2011. Emerg Infect Dis. 2012;18(5):842-5.

134. Kute VB, JG Goswami, Vanikar AV, Shah PR, Gumber MR, Patel HV, KV Kanodia, HL Trivedi. Unusual presentation of plasmodium vivax: A neglected human malaria parasite. Parasitol Res. 2012; 110(6):2573-6.

135. Kute VB, MP Patel, SB Patil, Shah PR, Vanikar AV, Gumber MR, Patel HV, JD Shrimali, Trivedi HL. Bronchiolitis obliterans organizing pneumonia (BOOP) after renal transplantation. Int Urol Nephrol. 2013;45(5):1517-21.

136. Kute VB, Vanikar AV, Ghuge PP, Goswami JG, Patel MP, Patel HV, Gumber MR, Shah PR, Trivedi HL. Renal cortical necrosis and acute kidney injury associated with Plasmodiumvivax: a neglected human malaria parasite. Parasitol Res. 2012;111(5):2213-6.

137. Kute VB, Gumber MR, Dhananjay KL, Vanikar AV, Yadav DK, Patel MP, Patel HV, Shah PR, Trivedi HL. Living donor exchange programs in renal transplantation: a paradigm readyfor broad implementation. Int Urol Nephrol. 2012 Jun 10. [Epub ahead of print].

138. Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Patel HV, Munjappa BC, ModiPR, Gera DN. Long-term outcome of deceased donor renal transplantation in pediatric recipients: A single-center experience from a developing country. Pediatr Transplant. 2012;16(6): 651-7.

139. Kute VB, Shah PR, Vanikar AV, Gumber MR, Goplani KR, Patel HV, Munjappa BC, HLTrivedi, Modi PR, Shah VR. Long-term Outcomes of Renal Transplants from Spousal andLiving-related and Other Living-unrelated Donors: A Single Center Experience. J Assoc Physicians India 2012; 60(7): 24-27.

140. Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Patel HV, Modi PR, ShahVR. Deceased donor renal transplantation from older donors to increase the donor pool. Int J ArtifOrgans. 2012; 35(9):663-70.

141. Vanikar AV, Trivedi HL. Stem Cell Transplantation in Living Donor Renal Transplantation for Minimization of Immunosuppression. Transplantation 2012; 94(8):845-850.

142. Dave SD, Vanikar A, Trivedi HL, Gumber MR, Patel HV, Shah PR, Kute VB. Stem Cells Versus Donor Specific Transfusions For Tolerance Induction In Living Donor Renal Transplantation: A Single-Center Experience. Transplantation 2013; 95(1):155-160.

24

143. Dave SD, Vanikar AV, Trivedi HL, Thakkar UG. Autologous Adipose Tissue Derived Insulin-Secreting Mesenchymal Stem Cell Transplantation In Late Onset of Autoimmune Mediated Diabetes Mellitus (LADA): Case Report. International Journal of Biomedical Research 2013; 4(3):153-156.

144. Dave SD, Vanikar AV, Trivedi HL. Extrinsic factors promoting in vitro differentiation of insulin-secreting cells from human adipose tissue-derived mesenchymal stem cell. Appl Biochem Biotechnol. 2013; 170(4): 962-71.

145. Dave SD, Vanikar AV, Trivedi HL. Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin making cells and hematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end stage renal disease. BMJ Case Rep. 2013 May 23; 2013.

146. Trivedi HL, Vanikar AV, Dave SD. Stable graft function on low-dose steroid monotherapyin spite of donor-specific antibodies in renal transplantation combined with stem cell infusion: Case Report. BMJ Case Rep. 2013 May 31; 2013.

147. Dave SD, Trivedi HL, Chooramani SG, Chandra T. Management of type 1diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells. BMJ Case Rep. 2013 Jul 26; 2013.

148. Trivedi HL, Vanikar AV. Mesenchymal Stem Cells and Solid Organ Transplantation. CellR4 2013; 1 (2): 123-36.

149. Trivedi HL, Vanikar AV, Kute VB, Patel HV, Gumber MR, Shah PR, Dave SD, Trivedi VB.The Effect of Stem Cell Transplantation on Immunosuppression in Living Donor Renal Transplantation: A Clinical Trial. Int J Org Transplant Med 2013; 4 (4): 155-162.

150. Kute VB, Patel MP, Patil SB, Shah PR, Vanikar AV, Gumber MR, Patel HV, Shrimali JD, Trivedi HL. Bronchiolitis obliterans organizing pneumonia (BOOP) after renal transplantation. Int Urol Nephrol. 2013; 45(5):1517-21.

151. Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Kanodia KV. Collapsing glomerulopathy and hemolytic uremic syndrome associated with falciparum malaria: completely reversible acute kidney injury. J Parasit Dis. 2013; 37(2): 286-290.

152. Trivedi HL, Nephrology and kidney transplantation in India: Past, present and future. Indian Journal of Transplantation 2014; 8:Sup.1:S10-S13.

153. Kute VB, Vanikar AV, Shah P R, Gumber MR, Patel H V, Trivedi HL. Mesangial proliferative glomerulonephritis with acute tubule interstitial nephritis leading to acute kidney injury in influenza A (H1N1) infection. Indian J Nephrol 2014; 24:114-6.

154. Kute VB, Vanikar AV, Shah PR, Gumber MR, Patel HV, Engineer DP, Modi PR, Shah VR,Trivedi HL .Does donor-recipient age difference matter in outcome of kidney transplantation? Implications for kidney paired donation.. Ren Fail. 2014; 36(3):378-383.

155. Kute VB, Vanikar AV, Gumber MR, Shah PR, Patel HV, Engineer DP, Balwani MR, Gautam RS, Gera DN, Modi PR, Shah VR, Trivedi HL. Successful three-way kidney paireddonation with compatible pairs to increase donor pool. Ren Fail. 2014;36(3): 447-450.

25

156. Kute VB, Vanikar AV, Shah PR, Gumber MR, Patel HV, Modi PR, Trivedi HL. Renal transplantation in secondary amyloidosis associated with Tuberculosis. Case Rep Transplant. 2013;2013:353529.

157. Dave SD, Vanikar AV, Trivedi HL, Thakkar UG, Gopal SC, Chandra T. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells. Clin Exp Med. 2013 Dec 7.

158. Vanikar AV, Trivedi HL, Kumar A, Gopal SC, Kute VB. Mesenchymal stem cells and transplant tolerance. Nephrology 2014; 19: 369–74.

159. Dave SD, Vanikar AV, Trivedi HL. In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1. Cytotechnology. 2014; 66(2):299-307.

26